Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.2 HKD | -0.57% | +0.19% | -21.69% |
May. 02 | Alphamab Oncology's 2023 Loss Narrows as Revenue Rises | MT |
Apr. 10 | Alphamab Oncology Presents Phase-I Clinical Trial Results at 2024 AACR Annual Meeting | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bearish | Bearish |
Resistance | 5.230 | 6.920 | 7.350 |
Spread/Res. | -0.57% | -24.86% | -29.25% |
Spread/Supp. | +13.04% | +34.72% | +28.40% |
Support | 4.600 | 3.860 | 4.050 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- 9966 Stock
- Charts Alphamab Oncology